Inverse-Vaccines for Rheumatoid Arthritis Re-establish Metabolic and Immunological Homeostasis in Joint Tissues

Area of Science:

• Immunology
• Metabolomics
• Systems Biology

Background:

• Rheumatoid arthritis (RA) involves complex immunological and metabolic dysregulation in joints.
• Understanding tissue homeostasis changes across RA stages is crucial for effective treatment.

Purpose of the Study:

• To examine immunological and metabolic profiles in early, intermediate, and late stages of collagen-induced arthritis (CIA).
• To evaluate the efficacy of the paKG(PFK15+bc2) microparticle inverse-vaccine in restoring tissue homeostasis during CIA progression.

Main Methods:

• Collagen-induced arthritis (CIA) mouse model.
• Immunological profiling of immune cell populations (pro-inflammatory vs. regulatory T-cells).
• Metabolomics analysis and flux metabolic modeling to identify affected pathways and metabolites.

Main Results:

• Inverse-vaccine treatment significantly reduced pro-inflammatory immune cells and increased regulatory T-cells in intermediate and late CIA stages.
• Spleen glycolysis normalized in late-stage CIA following inverse-vaccine treatment, resembling non-diseased states.
• Metabolites UDP-glucuronic acid and L-Glutathione oxidized were altered, suggesting potential druggable targets. Amino acid and carnitine pathways were identified as central to CIA progression.

Conclusions:

• The inverse-vaccine, paKG(PFK15+bc2) microparticle, effectively re-establishes tissue homeostasis in CIA.
• Early intervention with this inverse-vaccine promotes sustained restoration of immune and metabolic balance throughout the disease course.
• Identified metabolites and pathways offer novel targets for rheumatoid arthritis therapeutic development.